The Efficacy of BloodSTOP iX,Surgicel,and Gelfoam in Vascular Operations: First-in-Human Head-to-Head Study

Abstract

This study aims to compare the efficacy and safety of 3 different hemostatic agents in vascular surgeries in humans. Twenty-four patients were enrolled in the present study with 40 vascular anastomoses including 16 aortic and 24 femoral. The patients were randomized (computer-based) to either BloodSTOP iX, Gelfoam, or Surgicel. The hemostatic agent was applied at the site of the vascular anastomosis before declamping. The site of anastomosis was then observed for bleeding from the suture line for 2 min. If any bleeding was detected, blood was then collected for 5 min, and the time needed to stop bleeding was measured. A suction drain was fixed in the surgical bed to collect serous fluid postoperatively more than 48 h afterward. The volume of blood collected in 5 min was significantly lower in the BloodSTOP group compared with the other 2 hemostatics. There was a significant reduction in the mean time needed to stop bleeding from the anastomotic surface in the BloodSTOP group compared with the Surgicel and Gelfoam groups. In addition, Surgicel showed the highest rate of complication (46.2%) compared with BloodSTOP (7%). BloodSTOP iX dramatically reduced bleeding volume and time compared with the other hemostatic agents. Furthermore, it showed a lower complication rate and did not interfere with the healing process at the application sites.

Visual abstract

Keywords

BloodSTOP iX Surgicel Gelfoam hemostasis in humans

Get full access to this article

View all access options for this article.

References

Zimmerman

and Veith

. Great ideas in the history of surgery. San Francisco: Norman Publishing, 1993.

Sileshi

Achneck

and Lawson

. Management of surgical hemostasis: topical agents. Vascular 2008; 16: S22–S28.

Aubourg

Putzolu

Bouche

, et al. Surgical hemostatic agents: assessment of drugs and medical devices. J Vasc Surg 2011; 148: e405–e408.

Rysava

Dyr

Homola

, et al. Surface interactions of oxidized cellulose with fibrin(ogen) and blood platelets. Sens Actuators B Chem 2003; 90: 243–249.

Larson

. Topical hemostatic agents for dermatologic surgery. J Dermatol Surg Oncol 1988; 14: 623–632.

Morrison

Mountain

Galbraith

, et al. Penetrating pelvic battlefield trauma: internal use of chitosan-based hemostatic dressings. Injury 2010; 41: 239–241.

Wright

Hua

Velmahos

, et al. Intracorporeal use of the hemostatic agent QuickClot in a coagulopathic patient with combined thoracoabdominal penetrating trauma. J Trauma 2004; 56: 205–208.

Littlejohn

Bennett

and Drew

. Application of current hemorrhage control techniques for backcountry care: part two, hemostatic dressings and other adjuncts. Wilderness Environ Med 2015; 26: 246–254.

Bennett

Littlejohn

Kheirabadi

, et al. Management of external hemorrhage in tactical combat casualty care: chitosan-based hemostatic gauze dressings–TCCC guidelines-change 13-05. J Spec Oper Med 2014; 14: 40–57.

10.

Acheson

Kheirabadi

Deguzman

, et al. Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. J Trauma 2005; 59: 865–874.

11.

Mankad

and Codispoti

. The role of fibrin sealants in hemostasis. Am J Surg 2001; 182(2 Suppl): 21S–28S.

12.

Dowling

Kumar

Keibler

, et al. A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action. Biomaterials 2011; 32: 3351–3357.

13.

Brant

. The core curriculum: ultrasound. Philadelphia: Lippincott, Williams & Wilkins, 2001.

14.

Roizen

Beaupre

Alpert

, et al. Monitoring with two-dimensional transesophageal echocardiography: comparison of myocardial function in patients undergoing supra-celiac, suprarenal-infraceliac, or infrarenal aortic occlusion. J Vasc Surg 1984; 1: 300–305.

15.

Liang

. Doppler flow measurement of lower extremity arteries adjusted by pulsatility. Am J Roentgenol 2020; 214: 10–17.

16.

Ferretti

Qiu

Villalta

, et al. Efficacy of BloodSTOP iX, Surgicel, and Gelfoam in rat models of active bleeding from partial nephrectomy and aortic needle injury. Urology 2012; 80: 1161–1166.

17.

Ibarrola

Bjorenson

Austin

, et al. Osseous reactions to three hemostatic agents. J Endod 1985; 11: 75–83.

18.

Vyas

and Saha

. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther 2013; 13: 1663–1672.

19.

Mohamed

Christopher

and Christopher

. A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery. Eur J Cardiothorac Surg 2002; 22: 489–490.

20.

Patanè

Zingarelli

Verzini

, et al. Complication due to excessive use of Surgicel. Eur J Cardiothorac Surg 2001; 20: 1075–1076.

21.

Sandhu

Elexpuru-Camiruaga

and Buckley

. Oxidized cellulose (Surgicel) granulomata mimicking tumor recurrence. Br J Neurosurg 1996; 10: 617–619.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.22 MB